CD39+ regulatory T cells have been reported to accumulate in colon cancer and are associated with stronger capacity to dampen proinflammatory responses Th1 and Th17, suggesting these cells may be able to contribute to dampen antitumor responses that arise during PDAC development.34, 35, 47. This evidence concerns the gene ENTPD1 and malignant colon neoplasm.